Report Detail
Global Prescription Migraine Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4551304 |
- 22 August, 2023 |
- Global |
- 89 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Prescription Migraine Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Headaches and migraines are common conditions affecting a significant portion of the population. The increasing prevalence of these conditions drives the demand for prescription headache medicines as individuals seek effective treatment options to manage their symptoms. While over-the-counter medications can provide relief for many individuals with mild headaches, there is a substantial population that experiences moderate to severe headaches or migraines that require stronger prescription medications. The unmet medical needs of this population drive the demand for prescription headache medicines.
Prescription migraine medicines are medications that require a doctor's prescription and are specifically designed to treat migraines. These medications are typically more potent and targeted in their approach to managing migraine symptoms.
This report is a detailed and comprehensive analysis for global Prescription Migraine Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Migraine Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Prescription Migraine Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Prescription Migraine Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Prescription Migraine Medicine market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Migraine Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Prescription Migraine Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Teva, Pfizer, Amgen and Viatris, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Prescription Migraine Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sumatriptan
Rizatriptan
Others
Market segment by Application
Hospital
Clinic
Drug Store
Market segment by players, this report covers
GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prescription Migraine Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prescription Migraine Medicine, with revenue, gross margin and global market share of Prescription Migraine Medicine from 2018 to 2023.
Chapter 3, the Prescription Migraine Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Prescription Migraine Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Migraine Medicine.
Chapter 13, to describe Prescription Migraine Medicine research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Prescription Migraine Medicine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Prescription Migraine Medicine by Type
- 1.3.1 Overview: Global Prescription Migraine Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Prescription Migraine Medicine Consumption Value Market Share by Type in 2022
- 1.3.3 Sumatriptan
- 1.3.4 Rizatriptan
- 1.3.5 Others
- 1.4 Global Prescription Migraine Medicine Market by Application
- 1.4.1 Overview: Global Prescription Migraine Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Drug Store
- 1.5 Global Prescription Migraine Medicine Market Size & Forecast
- 1.6 Global Prescription Migraine Medicine Market Size and Forecast by Region
- 1.6.1 Global Prescription Migraine Medicine Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Prescription Migraine Medicine Market Size by Region, (2018-2029)
- 1.6.3 North America Prescription Migraine Medicine Market Size and Prospect (2018-2029)
- 1.6.4 Europe Prescription Migraine Medicine Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Prescription Migraine Medicine Market Size and Prospect (2018-2029)
- 1.6.6 South America Prescription Migraine Medicine Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Prescription Migraine Medicine Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 GSK
- 2.1.1 GSK Details
- 2.1.2 GSK Major Business
- 2.1.3 GSK Prescription Migraine Medicine Product and Solutions
- 2.1.4 GSK Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 GSK Recent Developments and Future Plans
- 2.2 Teva
- 2.2.1 Teva Details
- 2.2.2 Teva Major Business
- 2.2.3 Teva Prescription Migraine Medicine Product and Solutions
- 2.2.4 Teva Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Teva Recent Developments and Future Plans
- 2.3 Pfizer
- 2.3.1 Pfizer Details
- 2.3.2 Pfizer Major Business
- 2.3.3 Pfizer Prescription Migraine Medicine Product and Solutions
- 2.3.4 Pfizer Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Pfizer Recent Developments and Future Plans
- 2.4 Amgen
- 2.4.1 Amgen Details
- 2.4.2 Amgen Major Business
- 2.4.3 Amgen Prescription Migraine Medicine Product and Solutions
- 2.4.4 Amgen Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Amgen Recent Developments and Future Plans
- 2.5 Viatris
- 2.5.1 Viatris Details
- 2.5.2 Viatris Major Business
- 2.5.3 Viatris Prescription Migraine Medicine Product and Solutions
- 2.5.4 Viatris Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Viatris Recent Developments and Future Plans
- 2.6 Allergan
- 2.6.1 Allergan Details
- 2.6.2 Allergan Major Business
- 2.6.3 Allergan Prescription Migraine Medicine Product and Solutions
- 2.6.4 Allergan Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Allergan Recent Developments and Future Plans
- 2.7 Grunenthal
- 2.7.1 Grunenthal Details
- 2.7.2 Grunenthal Major Business
- 2.7.3 Grunenthal Prescription Migraine Medicine Product and Solutions
- 2.7.4 Grunenthal Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Grunenthal Recent Developments and Future Plans
- 2.8 Eli Lilly
- 2.8.1 Eli Lilly Details
- 2.8.2 Eli Lilly Major Business
- 2.8.3 Eli Lilly Prescription Migraine Medicine Product and Solutions
- 2.8.4 Eli Lilly Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Eli Lilly Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Prescription Migraine Medicine Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Prescription Migraine Medicine by Company Revenue
- 3.2.2 Top 3 Prescription Migraine Medicine Players Market Share in 2022
- 3.2.3 Top 6 Prescription Migraine Medicine Players Market Share in 2022
- 3.3 Prescription Migraine Medicine Market: Overall Company Footprint Analysis
- 3.3.1 Prescription Migraine Medicine Market: Region Footprint
- 3.3.2 Prescription Migraine Medicine Market: Company Product Type Footprint
- 3.3.3 Prescription Migraine Medicine Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Prescription Migraine Medicine Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Prescription Migraine Medicine Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Prescription Migraine Medicine Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Prescription Migraine Medicine Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Prescription Migraine Medicine Consumption Value by Type (2018-2029)
- 6.2 North America Prescription Migraine Medicine Consumption Value by Application (2018-2029)
- 6.3 North America Prescription Migraine Medicine Market Size by Country
- 6.3.1 North America Prescription Migraine Medicine Consumption Value by Country (2018-2029)
- 6.3.2 United States Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 6.3.3 Canada Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Prescription Migraine Medicine Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Prescription Migraine Medicine Consumption Value by Type (2018-2029)
- 7.2 Europe Prescription Migraine Medicine Consumption Value by Application (2018-2029)
- 7.3 Europe Prescription Migraine Medicine Market Size by Country
- 7.3.1 Europe Prescription Migraine Medicine Consumption Value by Country (2018-2029)
- 7.3.2 Germany Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 7.3.3 France Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 7.3.5 Russia Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 7.3.6 Italy Prescription Migraine Medicine Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Prescription Migraine Medicine Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Prescription Migraine Medicine Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Prescription Migraine Medicine Market Size by Region
- 8.3.1 Asia-Pacific Prescription Migraine Medicine Consumption Value by Region (2018-2029)
- 8.3.2 China Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 8.3.3 Japan Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 8.3.5 India Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 8.3.7 Australia Prescription Migraine Medicine Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Prescription Migraine Medicine Consumption Value by Type (2018-2029)
- 9.2 South America Prescription Migraine Medicine Consumption Value by Application (2018-2029)
- 9.3 South America Prescription Migraine Medicine Market Size by Country
- 9.3.1 South America Prescription Migraine Medicine Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Prescription Migraine Medicine Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Prescription Migraine Medicine Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Prescription Migraine Medicine Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Prescription Migraine Medicine Market Size by Country
- 10.3.1 Middle East & Africa Prescription Migraine Medicine Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Prescription Migraine Medicine Market Size and Forecast (2018-2029)
- 10.3.4 UAE Prescription Migraine Medicine Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Prescription Migraine Medicine Market Drivers
- 11.2 Prescription Migraine Medicine Market Restraints
- 11.3 Prescription Migraine Medicine Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Prescription Migraine Medicine Industry Chain
- 12.2 Prescription Migraine Medicine Upstream Analysis
- 12.3 Prescription Migraine Medicine Midstream Analysis
- 12.4 Prescription Migraine Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Prescription Migraine Medicine. Industry analysis & Market Report on Prescription Migraine Medicine is a syndicated market report, published as Global Prescription Migraine Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Prescription Migraine Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
